OVERVIEW

 

The Centre for Active Living is at the forefront of research dedicated to transforming how we prevent, treat, and manage health challenges in today’s evolving world. From harnessing cutting-edge technologies to develop breakthrough treatments for non-communicable and infectious diseases, to reimagining healthcare through digital innovation and interdisciplinary collaboration, the Centre is driven by a bold vision for the future of well-being.

 

Our researchers are advancing the science of active ageing, functional nutrition, and regenerative medicine to tackle pressing issues such as diabetes and age-related complications—empowering individuals not just to live longer, but to live better.

Purpose

To drive innovation in healthcare and well-being by leveraging technology, interdisciplinary research, and novel solutions that promote active living, healthy ageing, and improved outcomes for chronic and infectious diseases.

Mission 
To advance evidence-based scientific research to enhance health, well-being, and promote active living across all stages of life.

ABOUT US
RESEARCH CLUSTERS
PROJECTS
PUBLICATIONS
CONTACT US
ABOUT US RESEARCH CLUSTERS PROJECTS PUBLICATIONS CONTACT US

Researcher at the field
Shaping Healthier Futures Through Cross-Disciplinary Innovation

 

The Centre for Active Living (CAL) brings together experts from biosciences, pharmacy, preclinical and clinical medicine, engineering, and IT, united by a shared mission to enhance health and well-being across communities and populations. Through both discipline-specific and transdisciplinary research, we aim to enable people of all ages and health conditions to achieve active living.

 

Working collaboratively within the centre and with external partners, CAL addresses critical gaps in understanding health and disease. Our research leverages advanced technologies—from computational medicine and bioengineering to cell and tissue culture, surgical interventions, agri-tech, and personalised medicine—to tackle pressing challenges in healthcare, nutrition, and food security.

 

We are deeply engaged in both fundamental and applied research, including industry-driven initiatives, supported by institutional and external funding. Our commitment is clear: to turn innovative science into meaningful impact for healthier, more resilient communities.

OUR TEAM

 

The Centre for Active Living is driven by a diverse team of researchers, academics, and thought leaders united by a shared commitment to exploring Asia’s evolving landscape. 

URC Leaders

Portrait photo for Professor Chong Pei Pei

Professor Chong Pei Pei

 

Chair for the Center

Portrait photo for Associate Professor Dr Foo Jhi Biau

Associate Professor Dr Foo Jhi Biau

 

Cluster Lead for Drug Discovery and Molecular Medicine

Portrait photo for Dr Chan Sook Wah

Dr Chan Sook Wah

 

Cluster Lead for Food Innovation and Nutrition

Portrait photo for Ir Dr Eunice Phang Siew Wei

Ir Dr Eunice Phang Siew Wei

 

Cluster Lead for Regenerative Bioengineering and Computational Medicine

Portrait photo for Professor Dr Manohar A/L Arumugam

Professor Dr Manohar A/L Arumugam

 

Cluster Lead for Evidence-Based Therapeutics and Surgery

Portrait photo for Dr Punithavathy A/P Shanmuganathan

Dr Punithavathy A/P Shanmuganathan

 

Cluster Lead for Public Health and Disease Control Cluster

Drug Discovery and Molecular Medicine
Food Innovation and Nutrition
Regenerative Bioengineering and Computational Medicine
Evidence-Based Therapeutics and Surgery
Public Health and Disease Control

Drug discovery
Drug Discovery and Molecular Medicine

 

The research cluster is a dynamic, multidisciplinary team dedicated to tackling urgent health challenges through integrated basic research with translational potential.

 

Our expertise spans the entire drug development pipeline, with niche strengths in machine learning-enabled drug design, peptide and bioactive compound synthesis, natural product pharmacogenomics, and advanced delivery systems including nanoparticles and extracellular vesicles. We also drive innovations in stem cell-based therapeutics, anti-aging cosmeceuticals, and AMR-targeted solutions.

 

Bringing together experts in chemistry, pharmacology, formulation science, microbiology, and regenerative medicine, we foster deep collaboration to accelerate the translation of discoveries into impactful health solutions.

Value Proposition

Bridging science and patient care, we aim to generate innovations in therapeutics through AI-driven drug design, advanced delivery systems, and multidisciplinary research targeting today’s most critical health challenges.

UNSDGs Committed

  • #3: Good Health and Wellbeing

AREA OF FOCUS

Each focus area reflects a commitment to addressing complex societal challenges through interdisciplinary approaches, encouraging collaboration across fields to generate impactful insights and real-world solutions.

Cancer

Exploring novel therapeutics and delivery systems to improve cancer treatment outcomes and reduce side effects through targeted, personalised approaches.

Cosmetics and Dermatology

Advancing cosmeceutical formulations and dermatological therapies for skin health, anti-aging, and the treatment of conditions like atopic dermatitis and wound healing.

Infectious Diseases

Developing innovative solutions to combat antimicrobial resistance, enhance vaccine effectiveness, and address emerging viral and bacterial threats.

Metabolic Diseases

Investigating therapeutic strategies for obesity, diabetes, and related metabolic disorders by targeting underlying molecular mechanisms.

Neurodegenerative Diseases

Focusing on therapies that slow or reverse neurological decline, addressing conditions such as Alzheimer’s, Parkinson’s, and neuroinflammation-related disorders.

Research at the field
Food Innovation and Nutrition

 

This research cluster is a multidisciplinary team committed to advancing research that addresses critical challenges in food security, nutrition, and sustainable food systems. With a strong emphasis on collaboration with industry partners and community stakeholders, our work spans emerging processing techniques, agri-tech innovation, fermentation technologies, waste valorisation and circular economy models.

 

Our projects explore dietary interventions for non-communicable diseases and investigate the complex relationship between nutrition, gut health, and the microbiome—paving the way for personalised and preventive nutrition solutions.

Value Proposition

Driving sustainable and health-focused food solutions through cutting-edge research in in emerging food processing, agri-tech, nutrition, and microbiome science—transforming food systems for a healthier future.

UNSDGs Committed

  • #2: Zero Hunger
  • #3: Good Health and Wellbeing
  • #12: Responsible Consumption and Production
  • #13: Climate Action
  • #17: Partnerships For The Goals

AREA OF FOCUS

Each focus area reflects a commitment to addressing complex societal challenges through interdisciplinary approaches, encouraging collaboration across fields to generate impactful insights and real-world solutions.

Novel Food Ingredients

Developing innovative ingredients that enhance nutritional value, safety, and sustainability in modern food products.

Functional Foods

Creating foods with added health benefits beyond basic nutrition, aimed at improving overall well-being and preventing disease.

Nutraceuticals

Formulating bioactive compounds derived from food sources to support health, manage chronic conditions, and promote longevity.

Phytochemicals

Investigating plant-derived compounds with antioxidant, anti-inflammatory, and therapeutic properties for use in food and health applications.

Probiotics and Prebiotics

Exploring beneficial bacteria and non-digestible fibres that support gut health, boost immunity, and improve digestive function.

Alternative Proteins

Advancing sustainable protein sources such as plant-based, microbial, or insect-derived proteins to meet future food demands.

Data analytics
Regenerative Bioengineering and Computational Medicine

 

This research cluster is a multidisciplinary platform focused on developing next-generation healthcare technologies that merge advanced biomaterials, regenerative medicine, and computational intelligence. By integrating tissue engineering, stem cell therapeutics, and biofabrication with AI, digital diagnostics, and computational modelling, the cluster delivers innovative solutions to complex medical challenges.

 

With a strong emphasis on health issues affecting Malaysia and the wider Asian region—particularly those linked to ageing and diabetes-related complications—RBCM targets conditions such as chronic wounds, vascular degeneration, organ failure, and neuromuscular disorders.

 

The goal is to create scalable, translational technologies that significantly improve patient care and clinical outcomes.

Value Proposition

Bridging regenerative medicine with digital innovation, we aim to deliver cutting-edge, scalable solutions for age-related and chronic diseases—transforming personalised healthcare across Asia.

UNSDGs Committed

  • #3: Good Health and Wellbeing
  • #9: Industry, Innovation and Infrastructure

AREA OF FOCUS

Each focus area reflects a commitment to addressing complex societal challenges through interdisciplinary approaches, encouraging collaboration across fields to generate impactful insights and real-world solutions.

Tissue Engineering and Biofabrication

Developing engineered tissues and biofabricated constructs to restore or replace damaged biological structures.

Stem Cell-Based Therapeutics

Exploring stem cell applications for regenerative treatments, particularly for age-related and chronic conditions.

Advanced Biomaterials

Designing innovative materials to support tissue regeneration, wound healing, and implantable medical devices.

Computational Modelling and Artificial Intelligence

Using AI and computational simulations to optimise diagnostics, personalise treatments, and predict therapeutic outcomes.

Digital Diagnostics

Developing digital tools and platforms to enable early detection and monitoring of chronic and degenerative diseases.

Surgery ongoing
Evidence-Based Therapeutics and Surgery

 

This research cluster is a collaborative team of clinician-scientists and preclinical researchers dedicated to advancing medical interventions and surgical practices through rigorous evidence-based research.

 

By integrating systematic reviews, meta-analyses, clinical trials, and real-world clinical expertise, the cluster aims to support informed clinical decision-making and improve patient outcomes.

 

EBTS addresses key healthcare challenges such as information overload, inconsistencies in therapeutic practices, lack of transparency in clinical decisions, and unequal access to evidence-based care. Through a strong foundation in clinical research, the cluster drives innovation in precision medicine, surgical techniques, and patient-centred care to elevate the standard and equity of healthcare delivery..

Value Proposition

Empowering clinical excellence through evidence-based research, precision medicine, and surgical innovation to improve outcomes and promote equity in patient care.

UNSDGs Committed

  • #3: Good Health and Wellbeing
  • #10: Reduced Inequalities

AREA OF FOCUS

Each focus area reflects a commitment to addressing complex societal challenges through interdisciplinary approaches, encouraging collaboration across fields to generate impactful insights and real-world solutions.

Clinical Trials

Designing and conducting rigorous trials to evaluate the safety and effectiveness of medical and surgical interventions.

Systematic Reviews and Meta-Analyses

Synthesising existing research to provide high-quality evidence that informs clinical practice and healthcare guidelines.

Precision Medicine and Surgery

Tailoring treatments and surgical approaches to individual patient profiles for improved outcomes and reduced risk.

Evidence-Based Medical and Surgical Practices

Applying the best available scientific evidence to guide therapeutic and surgical decisions in clinical settings.

Innovations in Patient Care

Developing new methods and tools to enhance the quality, safety, and efficiency of healthcare delivery.

Clinical Decision-Making Improvement

Enhancing transparency and consistency in healthcare decisions by integrating research evidence with clinical expertise.

Researcher in the lab
Public Health and Disease Control

 

This research cluster is committed to advancing research in disease prevention and health promotion through both population-wide and individual-based interventions. By combining evidence-based strategies with community engagement, the cluster aims to reduce disease burden and improve overall public health outcomes.

 

Key initiatives include Knowledge, Attitudes, and Practices (KAP) surveys, health education, and behaviour change programmes designed to empower communities to manage their health and mitigate risk factors. Research areas span tobacco use, dengue prevention, HIV-related behaviour, and sexual health, with efforts grounded in public health and family medicine expertise.

 

The cluster also evaluates the real-world impact of health promotion and interventional strategies to drive measurable improvements in community well-being.

Value Proposition

Empowering communities through evidence-based health promotion and preventive strategies to reduce disease burden and build resilient public health systems.

UNSDGs Committed

  • #3: Good Health and Wellbeing

AREA OF FOCUS

Each focus area reflects a commitment to addressing complex societal challenges through interdisciplinary approaches, encouraging collaboration across fields to generate impactful insights and real-world solutions.

Disease Prevention and Health Promotion

Implementing strategies to reduce risk factors and promote healthier lifestyles across populations.

Community-Based KAP Surveys

Conducting surveys to understand public knowledge, attitudes, and practices, informing more targeted health interventions.

Tobacco Use Reduction

Researching and promoting behavioural change strategies to reduce smoking and tobacco-related harm.

Dengue Infection Prevention

Designing and evaluating interventions to reduce mosquito-borne infections through education and public health measures.

HIV and Sexual Health Behaviour

Investigating health behaviours and promoting awareness to reduce the transmission and stigma associated with HIV and sexual health issues.

Impact Assessment of Health Interventions

Measuring the effectiveness of health promotion and preventive approaches to inform public health policies and practices.

With strong industry partnerships, we strive to develop innovative solutions for a sustainable future, paving the way for a better tomorrow. Explore our initiatives and join us in making a positive difference.

Drug Discovery and Molecular Medicine
Food Innovation and Nutrition
Regenerative Bioengineering and Computational Medicine
Evidence-Based Therapeutics and Surgery
Public Health and Disease Control

Elucidating Anti-Inflammatory Potency and Mechanism of miRNA-146a-Enriched Exosomes Derived From Mesenchymal Stem Cells on Microglial Cells

Elucidating Anti-Inflammatory Potency and Mechanism of miRNA-146a-Enriched Exosomes Derived From Mesenchymal Stem Cells on Microglial Cells

Impact: Developing stem cell-derived exosomes enriched with miRNA-146a to suppress neuroinflammation, offering therapeutic potential for neurodegenerative diseases.

 

Funding: FRGS Grant (Oct 2023 – Oct 2025)

 

Project Members:

  • Dr Ooi Yin Yin (Project Leader)
  • Professor Dr Sharmili Vidyadaran
  • Associate Professor Dr Adeline Chia Yoke Yin
  • Associate Professor Dr Foo Jhi Biau

 

 
Deciphering the Stability, Pharmacokinetics, and Cellular Uptake of Combinatorial Pardaxin-derived Anticancer Peptides within Natural Killer Cells-Derived Exosomes/Liposome Hybrid System for Breast Cancer

Deciphering the Stability, Pharmacokinetics, and Cellular Uptake of Combinatorial Pardaxin-derived Anticancer Peptides within Natural Killer Cells-Derived Exosomes/Liposome Hybrid System for Breast Cancer

Impact: Enhancing delivery and uptake of anticancer peptides using hybrid systems to improve breast cancer treatment efficacy and reduce toxicity.

 

Funding: FRGS Grant (Oct 2024 – Oct 2027)

 

Project Members:

  • Dr Stella Tan Li Kar (Project Leader)
  • Associate Professor Dr Foo Jhi Biau
  • Dr Daniel Looi Qi Hao
  • Dr Lee Sau Har
  • Dr How Chee Wun

 

 
Fundamental Investigation of Intermolecular Interactions and Mechanical Properties of Crosslinked Oil Palm Frond Fiber Nanocellulose Loaded with Amoxicillin for Wound Infection

Fundamental Investigation of Intermolecular Interactions and Mechanical Properties of Crosslinked Oil Palm Frond Fiber Nanocellulose Loaded with Amoxicillin for Wound Infection

Impact: Designing sustainable, antibiotic-infused wound dressings with improved strength and controlled release using agricultural waste-derived nanocellulose.

 

Funding: FRGS Grant (Oct 2024 – Oct 2027)

 

Project Members:

  • Associate Professor Dr Looi Chung Yeng (Project Leader)
  • Dr Kong Yeo Lee
  • Dr Lee Sau Har
  • Dr Chan Sook Wah
  • Dr Mohd Yusof bin Harun
  • Dr Foo Ju Yen

 

 
Elucidating Precision Gene Targeting of CRISPR/Cas9 Ribonucleoproteins using Hepatitis B Virus-like Particles for EGFR Gene Silencing in Lung Cancer Cells

Elucidating Precision Gene Targeting of CRISPR/Cas9 Ribonucleoproteins using Hepatitis B Virus-like Particles for EGFR Gene Silencing in Lung Cancer Cells

Impact: Using virus-mimicking particles to deliver CRISPR/Cas9 for precise EGFR gene silencing, advancing precision oncology for lung cancer.

 

Funding: FRGS Grant (Oct 2024 – Oct 2027)

 

Project Members:

  • Dr Wong Chuan Loo (Project Leader)
  • Associate Professor Dr Adeline Chia Yoke Yin
  • Dr Tang Yin Quan
  • Professor Dr Tan Wen Siang
  • Associate Professor Dr Ho Kok Lian
  • Associate Professor Dr Mariatulqabtiah Abdul Razak

 

 
Elucidating The Mechanisms of Transepidermal Penetration, Cellular Uptake, and Skin Regeneration of Biomimetic Proniosomes for Tocotrienol-rich Fraction Delivery

Elucidating The Mechanisms of Transepidermal Penetration, Cellular Uptake, and Skin Regeneration of Biomimetic Proniosomes for Tocotrienol-rich Fraction Delivery

Impact: Investigating proniosomes for enhanced skin absorption and regeneration, contributing to anti-aging and dermatological innovations.

 

Funding: FRGS Grant (Aug 2024 – Jul 2027)

 

Project Members:

  • Dr Chu Chee Chin (Project Leader)
  • Dr.Wong Jia Woei
  • Professor Dr Nyam Kar Lin

 

 
Surface Modification of Oil Palm Mesocarp Fiber (OPMF) Derived Nanocellulose for Nanocomposite Hydrogels

Surface Modification of Oil Palm Mesocarp Fiber (OPMF) Derived Nanocellulose for Nanocomposite Hydrogels

Impact: Enhancing mechanical properties and functionality of nanocellulose hydrogels from palm waste for biomedical and environmental applications.

 

Funding: FRGS Grant (Oct 2023 – Sep 2026)

 

Project Members:

  • Dr Ng Jeck Fei (Project Leader)
  • Professor Dr Taufiq Yap Yun Hin (UPM)
  • Associate Professor Dr Mah Siau Hui (TU)
  • Associate Professor Dr Harisson Lau Lik Nang (MPOB)
  • Dr Teh Soek Sin (MPOB)

 

 
A Transcriptomic Profiling Study of Moringa Oleifera Leaf Extracts for the Identification of Wound Healing Mechanisms in Human Dermal Fibroblasts

A Transcriptomic Profiling Study of Moringa Oleifera Leaf Extracts for the Identification of Wound Healing Mechanisms in Human Dermal Fibroblasts

Impact: Using transcriptomic profiling to reveal wound-healing mechanisms of Moringa oleifera in dermal fibroblasts for plant-based therapy development.

 

Funding: FRGS Grant (Oct 2023 – Oct 2025)

 

Project Members:

  • Dr Chin Chai Yee (Project Leader)
  • Dr Lau Wing Man
  • Professor Leong Chee Onn
  • Dr Juriyati Jalil
  • Dr Sharina Hamzah

 

 
Metadynamics-Directed Modelling, Synthesis, and In Vitro Evaluation of High Affinity Quercetin Analogues Targeting Calcineurin

Metadynamics-Directed Modelling, Synthesis, and In Vitro Evaluation of High Affinity Quercetin Analogues Targeting Calcineurin

Impact: Designing high-affinity quercetin analogues through metadynamics for calcineurin-related immune modulation.

 

Funding: FRGS Grant (Oct 2023 – Oct 2025)

 

Project Members:

  • Dr Yau Mei Qian (Project Leader)
  • Associate Professor Dr Mah Siau Hui
  • Associate Professor Dr Foo Jhi Biau
  • Dr Agustono Wibowo
  • Dr Lee Fong Kai

 

 
Investigating The Involvement of the α-MSH And MITF Melanogenesis Pathways in The Depigmenting Activity of The Polar Microalga Chiarella in Vitro Melanocytes in Vitro

Investigating The Involvement of the α-MSH And MITF Melanogenesis Pathways in The Depigmenting Activity of The Polar Microalga Chiarella in Vitro Melanocytes in Vitro

Impact: Investigating melanogenesis pathways to support the use of polar microalgae as natural skin-lightening agents in cosmeceuticals.

 

Funding: FRGS Grant (Oct 2023 – Oct 2025)

 

Project Members:

  • Dr Teoh Ming Li (Project Leader)
  • Associate Professor Dr Yap Wei Hsum
  • Associate Professor Dr Mah Siau Hui
  • Dr Poong Sze Wan
  • Professor Dr Peter Convey

 

 

Unraveling the Stress-induced Secondary Metabolites Production of Aquilaria sinensis (Gaharu) Leaves in Response to Biological Inoculation

Unraveling the Stress-induced Secondary Metabolites Production of Aquilaria sinensis (Gaharu) Leaves in Response to Biological Inoculation

Impact: Enhancing flavonoid and xanthone production in Aquilaria sinensis leaves through biological inoculation for antioxidant-rich herbal and nutraceutical applications.

 

Funding: FRGS Grant (Aug 2025 – Jul 2026)

 

Project Members:

  • Dr Chan Sook Wah (Project Leader)
  • Professor Dr Tan Chin Ping
  • Associate Professor Dr Looi Chung Yeng
  • Dr Nallammai A/P Singaram
  • Dr Teoh Ming Li

 

 
The Role of Oral Microbiota on the Interactions Between Diet, Traditional Chinese Medicine Body Constitutions, and Depression Among Private University Students in Klang Valley, Malaysia

The Role of Oral Microbiota on the Interactions Between Diet, Traditional Chinese Medicine Body Constitutions, and Depression Among Private University Students in Klang Valley, Malaysia

Impact: Investigating oral microbiota's role in mediating the relationship between diet, TCM body types, and depression to inform culturally tailored mental health strategies.

 

Funding: FRGS Grant (Apr 2024 – Aug 2025)

 

Project Members:

  • Associate Professor Dr Foo Chai Nien (Project Leader)
  • Associate Professor Dr Yeo Siok Koon (Project Leader)
  • Professor Ts Dr Lim Yang Mooi
  • Associate Professor Ng Foong Leng
  • Dr Chua Lin Lin
  • Professor Datin Dr Sherina Mohd Sidik

 

 
Development of High-Protein Food Model and Assessing on the Mastication and Nutrient Digestion Profiles in Young Children and Older Adults

Development of High-Protein Food Model and Assessing on the Mastication and Nutrient Digestion Profiles in Young Children and Older Adults

Impact: Developing soft-textured, high-protein food models to improve nutrient intake and digestion in children and older adults for healthier, age-responsive diets.

 

Funding: Taylor's Internal Research Grant Scheme - Impact Lab Grant (Jun 2024 – Dec 2025)

 

Project Members:

  • Dr Leong Sze Ying (Project Leader)
  • Dr Chew Lye Yee
  • Ms Tracy Wong Fang Lian
  • AP Dr Neo Yun Ping (IMU University)

 

 

Smart Bandages for Accelerated Wound Healing in Diabetic Patients

Smart Bandages for Accelerated Wound Healing in Diabetic Patients

Impact: Developing herbal-infused smart bandages with bioactive hydrogels for infection control and tissue regeneration in chronic diabetic wounds.

 

Funding: Application on-going

 

Project Members:

  • Ir Dr Eunice Phang Siew Wei
  • Dr Bahman Nasiri-Tabrizi
  • Ir Dr Chow Yin Hui
  • Dr Chloe Chin Chai Yi

 

 
3D-Printed Bone Scaffold from Fish Bone-Derived Hydroxyapatite

3D-Printed Bone Scaffold from Fish Bone-Derived Hydroxyapatite

Impact: Fabricating sustainable, bioactive bone scaffolds from fish bone hydroxyapatite for cost-effective orthopedic regeneration.

 

Funding: Completed – Taylor’s Internal Research Grant Scheme (01 Jul 2018 – 30 Jun 2020); New funding application on-going

 

Project Members:

  • Ir Dr Eunice Phang Siew Wei
  • Dr Bahman Nasiri-Tabrizi
  • AP Ts Dr Choo Hui Leng
  • Dr Chloe Chin Chai Yi

 

 
Formulation of New Non-Newtonian Blood Mimicking Fluid for Angiography Imaging in the 3D-Printed Medical Simulator

Formulation of New Non-Newtonian Blood Mimicking Fluid for Angiography Imaging in the 3D-Printed Medical Simulator

Impact: Creating realistic blood-mimicking fluid for neurovascular simulation to enhance angiography training and surgical planning.

 

Funding: Completed – FRGS (01 Nov 2020 – 31 Oct 2024); New funding application on-going

 

Project Members:

  • Ir Dr Eunice Phang Siew Wei
  • Ir Dr Anis Suhaila Shuib (UTP)
  • Dr Hafisoh Ahmad
  • Ir Dr Wong Voon Loong (Xiamen University Malaysia)
  • Professor Dr Ahmad Sobrin bin Muda (Hospital Pengajar UPM)
  • Muhammad Izzat bin Ahmad Sabri (Lönge Medikal)

 

 

Stay tuned as we continue to share exciting developments on the project.

Stay tuned as we continue to share exciting developments on the project.

Drug Discovery and Molecular Medicine
Food Innovation and Nutrition
Regenerative Bioengineering and Computational Medicine
Evidence-Based Therapeutics and Surgery
Public Health and Disease Control

  • Yap SK, Tan KL, Abd Rahaman NY, Saulol Hamid NF, Ooi J, Tor YS, Daniel Looi QH, Stella Tan LK, How CW, Foo JB.
    Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Ameliorated Insulin Resistance in Type 2 Diabetes Mellitus Rats.
    Pharmaceutics. 2022; 14(3):649. (Impact Factor: 4.9)
 
  • Ahmad B, Friar EP, Vohra MS, Khan N, Serpell CJ, Garrett MD, Loo JSE, Fong IL, Wong EH.
    Hydroxylated polymethoxyflavones reduce the activity of pancreatic lipase, inhibit adipogenesis and enhance lipolysis in 3T3-L1 mouse embryonic fibroblast cells.
    Chemico-Biological Interactions. 2023; 379:110503. (Impact Factor: 4.7)
 
  • Siew WS, Tang YQ, Goh BH, Yap WH.
    The senescent marker p16INK4a enhances macrophage foam cells formation.
    Molecular Biology Reports. 2024; 51(1):1021. (Impact Factor: 2.6)
 
  • Tan SLK, How CW, Low LE, Ong BH, Loh JS, Lim SY, Ong YS, Foo JB.
    Magnetic-guided targeted delivery of zerumbone/SPION co-loaded in nanostructured lipid carrier into breast cancer cells.
    Journal of Drug Delivery Science and Technology. 2023; 87:104830. (Impact Factor: 4.5)
  • Yau MQ, Wan AJ, Tiong ASH, Yiap YS, Loo JSE.
    Leveraging binding pose metadynamics to optimise target fishing predictions for three diverse ligands and their true targets.
    Chemico-Biological Drug Design. 2024; 104(1):e14591. (Impact Factor: 3.2)
 
  • Chan SW, Mahmoud VL, Wang X, Teoh ML, Loh KM, Ng CH, Wong WF, Looi CY.
    Chemical profiling and cytotoxicity screening of agarwood essential oil (Aquilaria sinensis) in brine shrimp nauplii and cancer cell lines.
    PLOS ONE. 2024; 19(11):e0310770. (Impact Factor: 2.9)
 
  • Chu CC, Chew SC, Nyam KL.
    Synthesis and characterisation of chitosan-pectin fabricated nanoemulsion for ethylhexyl triazone topical delivery.
    Journal of Molecular Structure. 2025; 1321(5):140199. (Impact Factor: 4.0)

 

  • Tan FH, Ng JF, Mohamed Alitheen NB, Muhamad A, Yong CY, Lee KW.
    A simple and high efficiency purification of His-tagged turnip yellow mosaic virus-like particle (TYMV-VLP) by nickel ion affinity precipitation.
    Journal of Virological Methods. 2023; 319:114771. (Impact Factor: 2.2)

  • Tan YX, Chan SW, Wu EQ, Wang HX, Lou ZX.
    Fabrication of pH-responsive whey protein/sodium alginate composite hydrogel beads for Theaflavins.
    Journal of Food Engineering. 2024; 387:112324. https://doi.org/10.1016/j.jfoodeng.2024.112324
    (ISI-Indexed, Q1, Impact Factor: 5.3)

 

  • Yu Hsuan How, Michelle Yee Mun Teo, Lionel Lian Aun In, Siok Koon Yeo, Bhesh Bhandari, Liew Phing Pui.
    Freeze drying of food-grade recombinant Lactococcus lactis NZ3900-fermented milk with different protecting agents.
    International Dairy Journal. 2023; 146:105752. https://doi.org/10.1016/j.idairyj.2023.105752
    (ISI-Indexed, Q2, Impact Factor: 3.1)
  • Chang K-A, Ley S-L, Lee M-Y, Yaw H-Y, Lee S-W, Chew L-Y, Neo Y-P, Kong K-W.
    Determination of nutritional constituents, antioxidant properties, and α-amylase inhibitory activity of Sechium edule (chayote) shoot from different extraction solvents and cooking methods.
    Journal of Functional Foods. 2021; 151:112177.
    (ISI-Indexed, Q1, Impact Factor: 6.0)

  • Aissvarya S., Ling K-H, Arumugam M., Thilakavathy K.
    Molecular genetics of Dupuytren’s contracture.
    EFORT Open Reviews. 2024; 9(8):723–732.
 
  • Looi C., Arumugam M., Liew SK, Firdati MS.
    Preparations with catastrophic side effects: A case of neck of femur fracture due to secondary osteoporosis with underlying hip osteonecrosis resulting from chronic jamu consumption.
    Journal of Orthopaedics, Trauma and Rehabilitation. 2022; 29(2).
 
  • Nasiri-Tabrizi B., Basirun WJ, Walvekar R., Yeong CH, Phang SW.
    Exploring the potential of intermetallic alloys as implantable biomaterials: A comprehensive review.
    Biomaterials Advances. 2024; 213854.
  • Yu J., Wang Y., Dai Z., Yang F., Fallahpour A., Nasiri-Tabrizi B.
    Structural features modeling of substituted hydroxyapatite nanopowders as bone fillers via machine learning.
    Ceramics International. 2021; 47(7):9034–9047. (Impact Factor: 5.1)
 
  • Sarraf M., Nasiri-Tabrizi B., Yeong CH., Hosseini HRM, Saber-Samandari S., Basirun WJ., Tsuzuki T.
    Mixed oxide nanotubes in nanomedicine: A dead-end or a bridge to the future?
    Ceramics International. 2021; 47(3):2917–2948. (Impact Factor: 5.1)

 

  • Song HS., Ahamed F., Lee JY., Henry CS., Edirisinghe JN., Nelson WC., ... Scheibe TD.
    Coupling flux balance analysis with reactive transport modeling through machine learning for rapid and stable simulation of microbial metabolic switching.
    Scientific Reports. 2025; 15(1):6042. (Impact Factor: 3.8)

  • Tan HY, Wong YH, Kasbollah A., Shah MNM, Abdullah BJJ, Perkins AC, Yeong CH.
    Biodistribution and long-term toxicity of neutron-activated Samarium-153 oxide-loaded polystyrene microspheres in healthy rats.
    Nuclear Medicine and Biology. 2025; 146–147:109026. (Impact Factor: 3.6)
 
  • Ding J., Yeong C.
    Advances in DLL3-targeted therapies for small cell lung cancer: challenges, opportunities, and future directions.
    Frontiers in Oncology. 2024; 14:1504139. (Impact Factor: 3.5)
  • Jamal N., Krisanachinda A., Tsapaki V., Islam MR., Pawiro S., Al Omari M., Yeong CH., Myint TT., Kakakhel MB., Kharita MH., Lee CLJ., Ismail A., Nguyen TB., Knoll P., Ciraj-Bjelac O., Malek M.
    Strengthening education and training programmes for medical physics in Asia and the Pacific: the IAEA non-agreement technical cooperation (TC) regional RAS6088 project.
    Physical and Engineering Sciences in Medicine. 2024; 47(3):1167–1176. (Impact Factor: 2.4)

Stay tuned as we continue to share exciting developments on the work of our research.

Have questions or want to learn more about our research? Whether you're a prospective collaborator, researcher, student, or industry partner, we welcome your enquiries. Get in touch with us to explore opportunities, request information, or start a conversation.

CAL

Centre for Active Learning

Taylor's Lakeside Campus,

Subang, Malaysia

 

cal@taylors.edu.my

OTHER RESEARCH CENTRES